PolyNovo announced today that the first patient has been enrolled in their funded burn study. This study trial is being carried out in 20 US and 5 Canadian burn centres and will have up to 150 full thickness burn patients in a comparative study against the existing standard of care. The study is estimated to take about 3 years.
When the study concludes, Polynovo will make a premarket approval application with the US FDA for the use of their patented NovoSorb product in treating full thickness burns. 

I'm very confident that the data from this study will accelerate the use of Novosorb as the preferred standard of care when treating full thickness burns patients.